TuisHLUBF • OTCMKTS
add
H Lundbeck A/S Class A
Vorige sluiting
$4,82
Jaarwisseling
$4,59 - $6,41
Markkapitalisasie
40,80 mjd DKK
Gemiddelde volume
20,00
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
CPH
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (DKK) | Des. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 6,09 mjd | 9,96% |
Bedryfskoste | 4,36 mjd | 12,55% |
Netto inkomste | -27,00 m | -104,58% |
Netto winsgrens | -0,44 | -104,13% |
Wins per aandeel | 0,94 | -30,88% |
EBITDA | 956,00 m | -2,65% |
Effektiewe belastingkoers | 107,50% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (DKK) | Des. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 3,43 mjd | -26,39% |
Totale bates | 52,05 mjd | -9,72% |
Totale aanspreeklikheid | 27,15 mjd | -16,84% |
Totale ekwiteit | 24,90 mjd | — |
Uitstaande aandele | 991,23 m | — |
Prys om te bespreek | 0,19 | — |
Opbrengs op bates | 2,33% | — |
Opbrengs op kapitaal | 3,31% | — |
Kontantvloei
Netto kontantverandering
| (DKK) | Des. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -27,00 m | -104,58% |
Kontant van bedrywe | 921,00 m | 179,81% |
Kontant van beleggings | -202,00 m | 98,65% |
Kontant van finansiering | -765,00 m | -106,15% |
Netto kontantverandering | -46,00 m | 98,74% |
Beskikbare kontantvloei | 944,38 m | -46,59% |
Meer oor
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
Gestig
14 Aug. 1915
Webwerf
Werknemers
5 039
